TEVA PHARMACEUTICAL INDUSTRIES LTD

TEVA

Form 4 • Statement of Changes in Beneficial Ownership

SEC Accession Number: 0001193125-26-093938
Filing date: Mar 5, 2026
Earliest execution date: Mar 3, 2026
Reporting Owners: Sabag Mark (See "Remarks")

Summary

Type

Neutral

Net shares

0

% of shares

0.00%

Amount (USD)

$0

Insider confidence score

52.5 out of 100

Positive

  • Minimal sell amount (<$10K)

Stock transactions

Transaction 1

Security

Ordinary Shares

Action

Exercise

Date

2026-03-03

Code

M

Net shares

+24,900.0

Acquired/Disposed

Acquired

Shares Owned Before

52,828.0

Shares Owned After

77,728.0

Transaction 2

Security

Ordinary Shares

Action

Exercise

Date

2026-03-03

Code

M

Net shares

+141,478.0

Acquired/Disposed

Acquired

Shares Owned Before

77,728.0

Shares Owned After

219,206.0

Derivative Transactions

Transaction 1

Security

Restricted Share Units

Action

Exercise

Date

2026-03-03

Code

M

Net shares

-24,900.0

Acquired/Disposed

Disposed

Shares Owned Before

49,801.0

Shares Owned After

24,901.0

Transaction 2

Security

Restricted Share Units

Action

Exercise

Date

2026-03-03

Code

M

Net shares

-141,478.0

Acquired/Disposed

Disposed

Shares Owned Before

141,478.0

Shares Owned After

0.0

Filing's footnotes

1. The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share.

2. Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources and Compensation Committee, the cash value of one ordinary share.

3. Restricted share units were granted on March 3, 2024, with 24,900 vested on each of March 3, 2024, March 3, 2025 and March 3, 2026, and 24,901 vesting on March 3, 2027.

4. Restricted share units were earned on January 27, 2026, as a result of the satisfaction of certain performance criteria certified by the Human Resources and Compensation Committee and subsequently vested on March 3, 2026, following satisfaction of the time-based vesting criteria.

This page is for informational purposes only. While we strive for accuracy, the summary may contain inaccuracies or omissions. Please refer to the official SEC filing for authoritative information. Open the SEC filing.